Author + information
- Received June 11, 2018
- Revision received September 13, 2018
- Accepted October 19, 2018
- Published online March 4, 2019.
- Denisa Muraru, MD, PhDa,b,
- Rebecca T. Hahn, MDc,
- Osama I. Soliman, MDd,
- Francesco F. Faletra, MDe,
- Cristina Basso, MDa and
- Luigi P. Badano, MD, PhDa,b,∗ ()
- aDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy
- bIRCCS, Instituto Auxologico Italiano, S. Luca Hospital, University of Milano-Bicocca, Milan, Italy
- cColumbia University Medical Center, New York-Presbyterian Hospital, New York, New York
- dDepartment of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands
- eDepartment of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland
- ↵∗Address for correspondence:
Dr. Luigi P. Badano, IRCCS, Istituto Auxologico Italiano, S. Luca Hospital, University of Milano-Bicocca, Milan, Italy.
Tricuspid regurgitation (TR) is an independent predictor of death. Lately, emerging technologies for the treatment of TR have increased the interest of physicians. Due to the complex 3-dimensional (3D) geometry of the tricuspid valve (TV) and its anterior position in the mediastinum, conventional 2D echocardiography is unsuitable to study the anatomy and pathophysiologic mechanisms of the regurgitant TV. 3D echocardiography has emerged as a very cost-effective imaging modality with which to: 1) visualize the TV anatomy; 2) define the mechanism of TR; 3) measure the size and geometry of the tricuspid annulus; 4) analyze the anatomic relationships between TV apparatus and surrounding cardiac structures; 5) assess volumes and function of the right atrium and ventricle; and 6) plan surgical repair or guide and monitor transcatheter interventional procedures.
Dr. Muraru has received research support and speaker fees from and consults for GE Healthcare; and has received research support from TomTec Imaging Systems. Dr. Badano has received research support from GE Healthcare, Siemens, and TomTec Imaging systems; and is a member of the GE Healthcare Speakers Bureau. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received June 11, 2018.
- Revision received September 13, 2018.
- Accepted October 19, 2018.
- 2019 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.